BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 3, 2019
View Archived Issues
Bragsin inhibits BRAG2-mediated Arf GTPase activation in vitro in a membrane-dependent manner
Read More
MIT discovers high-affinity peptide-based PPI inhibitors using noncanonical amino acids
Read More
Pericytes rebuild muscle mass
Read More
Protecting the brain in sepsis
Read More
Melatonin receptor structure solved
Read More
Potential chemokine biomarkers for proliferative vitreoretinopathy in primary retinal detachment
Read More
Novel dimerizing agent immunoreceptor complex NKG2D-DARIC shows robust in vitro activity
Read More
New therapeutic protein reduces B-cell signaling
Read More
New gene therapy VTX-803 shows preclinical efficacy for the treatment of PFIC3
Read More
Patient recruitment ongoing in phase III study of sitravatinib plus nivolumab in NSCLC
Read More
Initiation of first-in-human study of YL-13027 in solid tumors
Read More
AMAL Therapeutcs to evaluate ATP-128 plus BI-754091 in phase I study
Read More
Cidara Therapeutics presents initial data from phase II STRIVE study of rezafungin
Read More
Urinary EGF as a new biomarker of progression of renal disease in children with nephrotic syndrome
Read More
Galectin-4 as a novel biomarker in infants with intestinal disease
Read More
Samumed launches phase III clinical program for lorecivivint in knee osteoarthritis
Read More
Novel LFA-1 antagonist VVN-001 for treating dry eye disease
Read More
Phase III study of Trelegy Ellipta in uncontrolled asthma meets primary endpoint
Read More
FDA issues second complete response letter for Barhemsys
Read More
FDA approves Tibsovo for newly diagnosed IDH1 mutant AML ineligible for intensive chemotherapy
Read More
Qternmet XR approved in U.S. for type 2 diabetes
Read More
Shanghai De Novo Pharmatech patents adenosine A2A receptor antagonists
Read More
Merck & Co. presents indoleamine 2,3-dioxygenase 1 inhibitors
Read More
Boehringer Ingelheim identifies new Bruton tyrosine kinase inhibitors
Read More
New PTP-2C inhibitors synthesized at REVOLUTION Medicines
Read More
Bristol-Myers Squibb discloses new STING agonists
Read More